Enlivex Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Enlivex Therapeutics (ENLV) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Enlivex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enlivex Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enlivex Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $104 | 100 | 1.04 |
| 2025-03-31 | $1.9k | 1.9k | 0.97 |
| 2024-12-31 | $3.0k | 2.6k | 1.17 |
| 2024-09-30 | $3.0k | 1.8k | 1.68 |
| 2024-06-30 | $327 | 231 | 1.42 |
| 2024-03-31 | $27k | 7.2k | 3.79 |
| 2023-12-31 | $639 | 237 | 2.70 |
| 2023-09-30 | $1.9k | 1.2k | 1.58 |
| 2023-06-30 | $6.3k | 2.4k | 2.63 |
| 2023-03-31 | $0 | 72 | 0.00 |
| 2022-12-31 | $0 | 98 | 0.00 |
| 2022-03-31 | $6.0k | 1.2k | 5.21 |
| 2020-03-31 | $3.0k | 621 | 4.83 |